Abstract
Rotavirus outer-layer protein VP7 is a principal target of protective antibodies. Removal of free calcium ions (Ca2+) dissociates VP7 trimers into monomers, releasing VP7 from the virion, and initiates penetration-inducing conformational changes in the other outer-layer protein, VP4. We report the crystal structure at 3.4 angstrom resolution of VP7 bound with the Fab fragment of a neutralizing monoclonal antibody. The Fab binds across the outer surface of the intersubunit contact, which contains two Ca2+ sites. Mutations that escape neutralization by other antibodies suggest that the same region bears the epitopes of most neutralizing antibodies. The monovalent Fab is sufficient to neutralize infectivity. We propose that neutralizing antibodies against VP7 act by stabilizing the trimer, thereby inhibiting the uncoating trigger for VP4 rearrangement. A disulfide-linked trimer is a potential subunit immunogen.
MeSH Terms
Amino Acid Sequence
Antibodies, Monoclonal/chemistry,immunology,metabolism
Antibodies, Viral/chemistry,immunology,metabolism
Antigens, Viral/chemistry,genetics,immunology,metabolism
Binding Sites
Binding Sites, Antibody
Calcium/metabolism
Capsid Proteins/chemistry,genetics,immunology,metabolism
Crystallography, X-Ray
Epitopes/immunology
Immunoglobulin Fab Fragments/chemistry,immunology,metabolism
Models, Molecular
Molecular Sequence Data
Mutation
Neutralization Tests
Protein Folding
Protein Multimerization
Protein Structure, Tertiary
Protein Subunits
Recombinant Proteins/chemistry
Rotavirus/chemistry,immunology
Serotyping
Chemicals
Antibodies, Monoclonal
Antibodies, Viral
Antigens, Viral
Capsid Proteins
Epitopes
Immunoglobulin Fab Fragments
Protein Subunits
Recombinant Proteins
VP7 protein, Rotavirus
Calcium
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Aoki Scott T
Laboratory of Molecular Medicine, Children's Hospital, Boston, MA 02115, USA.
Settembre Ethan C
Trask Shane D
Greenberg Harry B
Harrison Stephen C
Dormitzer Philip R
References (25)
25 references, click to expand
-
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
Vaccine. 2008 Dec 9;26(52):6754-8
PMID: 18951937
-
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction.
J Cell Biol. 1990 Jun;110(6):2133-44
PMID: 2161857
-
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene.
J Virol. 1988 May;62(5):1819-23
PMID: 2833626
-
Three-dimensional structure of rotavirus.
J Mol Biol. 1988 Jan 20;199(2):269-75
PMID: 2832610
-
Intracellular manipulation of disulfide bond formation in rotavirus proteins during assembly.
J Virol. 1994 Aug;68(8):5204-15
PMID: 8035518
-
Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry.
J Virol. 2003 Sep;77(18):9969-78
PMID: 12941907
-
Rotavirus and severe childhood diarrhea.
Emerg Infect Dis. 2006 Feb;12(2):304-6
PMID: 16494759
-
The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin.
Virology. 1991 Apr;181(2):553-63
PMID: 1849677
-
Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins.
J Virol. 2006 Nov;80(22):11293-304
PMID: 16971442
-
Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus.
Virology. 1988 Aug;165(2):511-7
PMID: 2457279
-
Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
J Virol. 2002 Jul;76(13):6643-51
PMID: 12050377
-
The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression.
J Virol. 1990 Oct;64(10):4776-83
PMID: 2168965
-
Three-dimensional visualization of the rotavirus hemagglutinin structure.
Cell. 1993 Aug 27;74(4):693-701
PMID: 8395350
-
Selective depletion of stored calcium by thapsigargin blocks rotavirus maturation but not the cytopathic effect.
J Virol. 1995 Jun;69(6):3838-47
PMID: 7745732
-
Presentation of neutralizing epitopes by engineered rotavirus VP7's expressed by recombinant vaccinia viruses.
Virology. 1994 Oct;204(1):391-402
PMID: 7522373
-
Rotavirus VP7 neutralization epitopes of serotype 3 strains.
Virology. 1989 Aug;171(2):503-15
PMID: 2474892
-
Structural rearrangements in the membrane penetration protein of a non-enveloped virus.
Nature. 2004 Aug 26;430(7003):1053-8
PMID: 15329727
-
Purified recombinant rotavirus VP7 forms soluble, calcium-dependent trimers.
Virology. 2000 Nov 25;277(2):420-8
PMID: 11080489
-
Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes.
J Clin Microbiol. 2008 Feb;46(2):462-9
PMID: 18057127
-
Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine.
Rev Med Virol. 2005 Jan-Feb;15(1):29-56
PMID: 15484186
-
Antigenic mapping of the surface proteins of rhesus rotavirus.
Virology. 1986 Dec;155(2):434-51
PMID: 2431540
-
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
J Virol. 1991 May;65(5):2211-9
PMID: 1850007
-
Silencing the morphogenesis of rotavirus.
J Virol. 2005 Jan;79(1):184-92
PMID: 15596814
-
Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype.
J Virol. 1991 Nov;65(11):5968-74
PMID: 1656083
-
Two proline residues are essential in the calcium-binding activity of rotavirus VP7 outer capsid protein.
J Virol. 1997 Mar;71(3):2211-6
PMID: 9032355